H4961 is a Massachusetts health insurance and patient-access bill aimed at improving coverage and continuity of care for people who use ostomy supplies or need supplies for fistula management. The bill requires a broad set of public and private health coverage arrangements — including the Group Insurance Commission, Medicaid-related coverage, commercial insurers, Blue Cross/Blue Shield-type plans, HMOs, and other health service plans — to cover all medically necessary ostomy-related supplies and supplies for surgically created or spontaneous fistulas, including supplies related to ostomy complications. It also bars insurers and plans from conditioning coverage on the use of non-medical supplies.
The bill adds several patient-protection rules. When a patient changes health coverage, ostomy care information, history, and prescriptions must be transferred within 72 hours, and supply orders and shipments cannot be interrupted during the transition. Prescriptions for ostomy supplies must remain valid for at least one year, may exceed ordinary quantity limits when medically necessary, and cannot be delayed by prior authorization, approval, or appeal processes. Suppliers must give one month’s notice before prescription expiration and before any brand substitution, and if a substituted product is inferior, the patient must be allowed to return to the original product or receive an equivalent one. The bill also requires hospitals performing ostomy surgery to have access to certified ostomy-care professionals and to provide appropriate outpatient follow-up.
In addition to coverage mandates, the bill sets reimbursement and transparency standards. Health payers must reimburse ostomy supply suppliers at no less than the Medicare reimbursement rate, and insurers and plans must make public information about their ostomy coverage. The bill applies these requirements across multiple chapters of the General Laws, including laws governing state employee insurance, Medicaid, commercial insurers, hospital service corporations, medical service corporations, and HMOs, thereby creating a uniform statewide standard for ostomy-related coverage and supply access.
The overall sentiment reflected in the available record is favorable. The House Committee on Financial Services reported the bill ought to pass, and there is no recorded opposition, vote split, or committee transcript in the provided materials. The bill’s framing as an access-to-care measure suggests support for patients and providers seeking more reliable coverage and fewer disruptions in ostomy treatment.
The main points of potential contention are the cost and administrative burden on insurers, public programs, hospitals, and suppliers. Requiring coverage of all ostomy-related supplies, reimbursement at or above Medicare rates, rapid transfer of patient records, and restrictions on non-medical switching could increase expenses and limit plan flexibility. Hospitals and suppliers may also face compliance obligations tied to staffing, notice requirements, and dispensing rules. No specific opponents are identified in the record, but these are the likely policy issues raised by stakeholders.
The bill would amend multiple chapters of Massachusetts law to impose uniform coverage, reimbursement, and continuity-of-care requirements for ostomy-related supplies and fistula-management supplies across public and private health plans. It would affect state employee coverage, Medicaid managed care, commercial insurance, hospital service corporations, medical service corporations, and HMOs, while also imposing related requirements on hospitals and licensed physicians and suppliers. The bill would create new statutory protections against coverage interruptions, prior authorization delays, and non-medical switching, and would require reimbursement at no less than Medicare rates.
The available legislative record shows a positive or supportive posture toward the bill. The House Committee on Financial Services recommended that the bill ought to pass, and there are no recorded votes or transcript excerpts indicating opposition or controversy in the provided materials. Based on the bill’s purpose and committee action, the measure appears to have been received as a patient-access and consumer-protection bill.
The likely areas of contention are fiscal and operational rather than ideological. Insurers, public payers, and health plans may object to mandated coverage, minimum reimbursement tied to Medicare, and limits on utilization management tools such as prior authorization and product substitution. Suppliers and hospitals may face added administrative duties, including notice requirements, record-transfer deadlines, and staffing expectations for certified ostomy-care professionals. No specific stakeholder objections are documented in the provided record, but these are the most probable points of dispute.